发布求助
文献互助 智能选刊 最新文献

TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD最新文献

筛选
英文 中文
Prognosis of Idiopathic Pulmonary Fibrosis in the Antifibrotic Era Stratified by the GAP Score GAP评分对抗纤维化时代特发性肺纤维化预后的分级
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1901
J. Pastre, S. Valery, A. Brown, O. Shlobin, K. Ahmad, V. Khangoora, S. Aryal, C. King, S. Nathan
{"title":"Prognosis of Idiopathic Pulmonary Fibrosis in the Antifibrotic Era Stratified by the GAP Score","authors":"J. Pastre, S. Valery, A. Brown, O. Shlobin, K. Ahmad, V. Khangoora, S. Aryal, C. King, S. Nathan","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1901","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1901","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123356852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Time Since Diagnosis 尼达尼布对进展性纤维化间质性肺疾病(ILDs)患者强制肺活量(FVC)下降的影响
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1907
M. Strek, R. Hallowell, J. Kuś, H. Nunes, T. Suda, S. Tomassetti, H. Mueller, K. Rohr, K. Flaherty, on behalf of the INBUILD trial investigators
{"title":"Effect of Nintedanib on Decline in Forced Vital Capacity (FVC) in Patients with Progressive Fibrosing Interstitial Lung Diseases (ILDs) by Time Since Diagnosis","authors":"M. Strek, R. Hallowell, J. Kuś, H. Nunes, T. Suda, S. Tomassetti, H. Mueller, K. Rohr, K. Flaherty, on behalf of the INBUILD trial investigators","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1907","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1907","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117176134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Varying Severities of Cough 尼达尼布对特发性肺纤维化和不同严重程度咳嗽患者的影响
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1903
W. Wuyts, C. Vancheri, F. Bonella, A. Russell, D. Lievens, W. Stansen, M. Wijsenbeek
{"title":"Effects of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Varying Severities of Cough","authors":"W. Wuyts, C. Vancheri, F. Bonella, A. Russell, D. Lievens, W. Stansen, M. Wijsenbeek","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1903","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1903","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"2408 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130683210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Single-Center, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of MN-001 (Tipelukast) in Subjects with Idiopathic Pulmonary Fibrosis 一项评估MN-001(替鲁司特)在特发性肺纤维化患者中的疗效、安全性和耐受性的单中心、随机、安慰剂对照研究
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1898
R. Bascom, K. Hitz, Anne E. F. Dimmock, M. Makhay, K. Matsuda
{"title":"A Single-Center, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of MN-001 (Tipelukast) in Subjects with Idiopathic Pulmonary Fibrosis","authors":"R. Bascom, K. Hitz, Anne E. F. Dimmock, M. Makhay, K. Matsuda","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1898","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1898","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132979630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patterns of Follow Up and Rates of Transplant Referral in Patients with Interstitial Lung Disease on Antifibrotics in the Southern California Region 南加州地区间质性肺疾病患者抗纤维化药物的随访模式和移植转诊率
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1916
C. Lau, T. Thai, G.C. Cerro Chiang, K. Wei
{"title":"Patterns of Follow Up and Rates of Transplant Referral in Patients with Interstitial Lung Disease on Antifibrotics in the Southern California Region","authors":"C. Lau, T. Thai, G.C. Cerro Chiang, K. Wei","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1916","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1916","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"60 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128363830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Antifibrotic Therapy on Mortality and Survival Outcomes in Idiopathic Pulmonary Fibrosis 抗纤维化治疗对特发性肺纤维化患者死亡率和生存率的影响
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1909
S. Schecter, Vikas S. Koppurapu, Y. Zemkova, D. Barber, Y. Shim, A. Laroia, C. Lee, K. Ussavarungsi
{"title":"Effect of Antifibrotic Therapy on Mortality and Survival Outcomes in Idiopathic Pulmonary Fibrosis","authors":"S. Schecter, Vikas S. Koppurapu, Y. Zemkova, D. Barber, Y. Shim, A. Laroia, C. Lee, K. Ussavarungsi","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1909","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1909","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"7 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121604175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Tolerability of Low-Dose Nintedanib for Idiopathic Pulmonary Fibrosis in the Real World 低剂量尼达尼布治疗特发性肺纤维化的疗效和耐受性
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1904
M. Kato, Y. Arai, M. Tateyama, S. Nakazawa, H. Motomura, Y. Ochi, I. Sumiyoshi, J. Watanabe, H. Ihara, S. Togo, S. Sasaki, K. Takahashi
{"title":"Efficacy and Tolerability of Low-Dose Nintedanib for Idiopathic Pulmonary Fibrosis in the Real World","authors":"M. Kato, Y. Arai, M. Tateyama, S. Nakazawa, H. Motomura, Y. Ochi, I. Sumiyoshi, J. Watanabe, H. Ihara, S. Togo, S. Sasaki, K. Takahashi","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1904","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1904","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123048668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modelling Short-Term FVC Changes from SENSCIS to Long-Term FVC Course in SSc-ILD Demonstrates Clinically Meaningful Reduction of FVC Decline and Survival Benefits 模拟SSc-ILD患者从SENSCIS到长期FVC过程的短期FVC变化显示了FVC下降和生存益处的临床意义
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1912
O. Distler, D. Huscher, P. Airò, P. Carreira, Y. Allanore, U. Müller-Ladner, A. Giollo, C. de Souza Müller, R. Bečvář, M. Iudici, A. Gabrielli, M. Alves, N. Schoof, A. Hoffmann-Vold
{"title":"Modelling Short-Term FVC Changes from SENSCIS to Long-Term FVC Course in SSc-ILD Demonstrates Clinically Meaningful Reduction of FVC Decline and Survival Benefits","authors":"O. Distler, D. Huscher, P. Airò, P. Carreira, Y. Allanore, U. Müller-Ladner, A. Giollo, C. de Souza Müller, R. Bečvář, M. Iudici, A. Gabrielli, M. Alves, N. Schoof, A. Hoffmann-Vold","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1912","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1912","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"117265823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Antifibrotic Treatments for Acute Exacerbation of Idiopathic Pulmonary Fibrosis 特发性肺纤维化急性加重期抗纤维化治疗的疗效观察
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1910
K. Sugino, H. Ono, N. Watanabe, M. Ando, E. Tsuboi
{"title":"Efficacy of Antifibrotic Treatments for Acute Exacerbation of Idiopathic Pulmonary Fibrosis","authors":"K. Sugino, H. Ono, N. Watanabe, M. Ando, E. Tsuboi","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1910","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1910","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"2019 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122161389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH): Analysis of PH Key Assessments (Right Heart Catheterization Availability and Baseline NT-proBNP) 西地那非加吡非尼酮治疗晚期特发性肺纤维化(IPF)和肺动脉高压(PH)的风险:PH关键评估分析(右心导管可用性和基线NT-proBNP)
TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD Pub Date : 1900-01-01 DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1913
J. Behr, S. Nathan, S. Harari, W. Wuyts, K. Kirchgaessler, M. Bengus, F. Gilberg, A. Wells
{"title":"Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis (IPF) and Risk of Pulmonary Hypertension (PH): Analysis of PH Key Assessments (Right Heart Catheterization Availability and Baseline NT-proBNP)","authors":"J. Behr, S. Nathan, S. Harari, W. Wuyts, K. Kirchgaessler, M. Bengus, F. Gilberg, A. Wells","doi":"10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1913","DOIUrl":"https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1913","url":null,"abstract":"","PeriodicalId":333033,"journal":{"name":"TP28. TP028 APPROACH TO THERAPY IN FIBROSING AND NON-FIBROSING ILD","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123118697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信